As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

 3/22/24  Nutra Pharma Corp.                8-K:5,7,8,9 3/19/24   12:249K                                   M2 Compliance LLC/FA     
11/21/22  Nutra Pharma Corp.                10-Q        9/30/22   76:9M                                     M2 Compliance LLC/FA     
11/15/22  Nutra Pharma Corp.                NT 10-Q     9/30/22    1:27K                                    M2 Compliance LLC/FA     
 8/22/22  Nutra Pharma Corp.                10-Q        6/30/22   71:8.8M                                   M2 Compliance LLC/FA     
 8/15/22  Nutra Pharma Corp.                NT 10-Q     6/30/22    1:27K                                    M2 Compliance LLC/FA     
  8/4/22  Nutra Pharma Corp.                8-K:4,9     7/28/22   11:403K                                   M2 Compliance LLC/FA     
 5/20/22  Nutra Pharma Corp.                10-Q        3/31/22   71:8M                                     M2 Compliance LLC/FA     
 5/16/22  Nutra Pharma Corp.                NT 10-Q     3/31/22    1:27K                                    M2 Compliance LLC/FA     
 4/15/22  Nutra Pharma Corp.                10-K       12/31/21   76:9.6M                                   M2 Compliance LLC/FA     
  4/1/22  Nutra Pharma Corp.                NT 10-K    12/31/21    1:26K                                    M2 Compliance LLC/FA     
 3/24/22‡ Nutra Pharma Corp.                DEF 14C     3/23/22    1:175K                                   M2 Compliance LLC/FA     
 1/14/22  Deitsch Rik J                     5          Dir.,Off.²  1:6K   Nutra Pharma Corp.                M2 Compliance LLC/FA     
 1/14/22  Deitsch Rik J                     SC 13D/A               1:61K  Nutra Pharma Corp.                M2 Compliance LLC/FA     
 1/14/22  Nutra Pharma Corp.                PRE 14C     1/14/22    1:173K                                   M2 Compliance LLC/FA     
11/10/21  Nutra Pharma Corp.                10-Q        9/30/21   72:9.4M                                   M2 Compliance LLC/FA     
 9/24/21  Nutra Pharma Corp.                10-Q        6/30/21   72:9.8M                                   M2 Compliance LLC/FA     
 9/17/21  Nutra Pharma Corp.                10-Q        3/31/21   73:6.4M                                   M2 Compliance LLC/FA     
  9/8/21  Nutra Pharma Corp.                10-K       12/31/20   76:8.3M                                   M2 Compliance LLC/FA     
 8/12/21  Nutra Pharma Corp.                10-Q        9/30/20   72:7.9M                                   M2 Compliance LLC/FA     
  8/5/21  Nutra Pharma Corp.                10-Q        6/30/20   72:7.9M                                   M2 Compliance LLC/FA     

____________
‡	A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET.  The legal “Filed As Of” date may be the next, or another, day.
¹	Filing/Form Types:
	5	Annual Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 5 { The Filer is an Insider² of the Issuer }.
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
	10-K	Annual Report — Form 10-K.
	10-Q	Quarterly Report — Form 10-Q.
	DEF 14C	Definitive Proxy Info Statement — Schedule 14C.
	NT 10-K	Notice of a Late Filing of a Form 10-K Annual Report — Form 12b-25.
	NT 10-Q	Notice of a Late Filing of a Form 10-Q Quarterly Report — Form 12b-25.
	PRE 14C	Preliminary Proxy Info Statement — Schedule 14C.
	SC 13D	Statement of Acquisition of Beneficial Ownership by an “Active” Investor — Schedule 13D.
	/A	Amendment to, or Amended version of, a previous Filing of this Type.
²	Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.